Literature DB >> 6430907

The risk of haematogenous infection in total joint replacements.

D A Ainscow, R A Denham.   

Abstract

One thousand patients who received 1112 total joint replacements between 1966 and 1980 were followed up prospectively for an average of six years. These patients were not advised to take antibiotics prophylactically to cover subsequent dental or surgical procedures and, so far, only three cases of haematogenous infection at the site of the joint replacement have developed. Two hundred and twenty-four patients did subsequently undergo dental or surgical procedures and 284 patients developed infections in the respiratory tract, urinary tract or at multiple sites; none of these patients developed haematogenous infection. But of 40 patients who suffered recurrent skin ulceration and infection, three (7.5%) developed haematogenous infection of the replaced joint; two of these belonged to a group of 134 patients with rheumatoid arthritis. These results suggest that transient bacteraemia is not likely to infect a replaced joint in otherwise healthy patients. But an infected skin lesion producing chronic bacteraemia, or septicaemia due to a virulent organism, may well do so and patients with rheumatoid arthritis are at greater risk than those with osteoarthritis.

Entities:  

Mesh:

Year:  1984        PMID: 6430907

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  23 in total

1.  An infected prosthetic hip. Is there a role for prophylactic antibiotics?

Authors:  J C Mason; C T Dollery; A So; J Cohen; S R Bloom; C Bulpitt; R Russell-Jones; C M Oakley
Journal:  BMJ       Date:  1992-08-01

Review 2.  Cerebrospinal fluid diversion devices and infection. A comprehensive review.

Authors:  R Gutiérrez-González; G R Boto; A Pérez-Zamarrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

3.  Are antibiotics necessary in hip arthroplasty with asymptomatic bacteriuria? Seeding risk with/without treatment.

Authors:  José Cordero-Ampuero; Enrique González-Fernández; David Martínez-Vélez; Jaime Esteban
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

4.  Ultrasound examination of haematomas after total hip replacement.

Authors:  L Parrini; M Baratelli; M Parrini
Journal:  Int Orthop       Date:  1988       Impact factor: 3.075

5.  CORR Insights®: Is Elective Soft Tissue Hand Surgery Associated with Periprosthetic Joint Infection after Total Joint Arthroplasty?

Authors:  Ronald Emilio Delanois
Journal:  Clin Orthop Relat Res       Date:  2019-10       Impact factor: 4.176

6.  Prolene-Monocryl-composite meshes do not increase microvascular Staphylococcus aureus adherence and do not sensitize for leukocytic inflammation.

Authors:  Jonas Roller; Matthias W Laschke; Shneh Sethi; Mathias Herrmann; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2008-03-06       Impact factor: 3.445

7.  Prevalence of asymptomatic bacteriuria in knee arthroplasty patients and subsequent risk of prosthesis infection.

Authors:  David Martínez-Vélez; Enrique González-Fernández; Jaime Esteban; José Cordero-Ampuero
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-11-11

8.  Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty.

Authors:  Panagiotis Koulouvaris; Peter Sculco; Eileen Finerty; Thomas Sculco; Nigel E Sharrock
Journal:  Clin Orthop Relat Res       Date:  2008-11-14       Impact factor: 4.176

9.  Prosthetic joint infection, dental treatment and antibiotic prophylaxis.

Authors:  Marthinus J Kotzé
Journal:  Orthop Rev (Pavia)       Date:  2009-06-30

10.  Increased risk of prosthetic joint infection associated with esophago-gastro-duodenoscopy with biopsy.

Authors:  Nayantara Coelho-Prabhu; Amy S Oxentenko; Douglas R Osmon; Todd H Baron; Arlen D Hanssen; Walter R Wilson; James M Steckelberg; Larry M Baddour; William S Harmsen; Jay Mandrekar; Elie F Berbari
Journal:  Acta Orthop       Date:  2013-01-25       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.